Normal Pregnancy, Pregnancy Complications, and Obstetric Management



Profound changes in maternal physiology occur during pregnancy to accommodate the growing fetus. Understanding these changes is fundamental to proper management of the obstetric patient and identification of pathologic changes. This chapter provides an overview of the obstetric patient and serves to familiarize the rheumatologist with pregnancy. First, we address normal fetal development followed by the various maternal physiologic changes that occur in major organ systems. Next we address antenatal care and fetal surveillance. Finally, we discuss common complications of pregnancy, some of which may mimic rheumatologic conditions or occur in greater frequency in the woman with underlying rheumatic disease. This chapter lays the foundation required to understand the nuances of pregnancy management in each specific rheumatologic disease.


Down Syndrome Fetal Growth Restriction Hypertensive Disorder Gestational Hypertension Severe Preeclampsia 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Monga M. Maternal cardiovascular, respiratory, and renal adaptation to pregnancy. In: Creasy RK, Resnik R, Iams JD, Lockwood CJ, Moore TR, editors. Maternal-fetal medicine: principles and practice. 6th ed. Philadelphia: Saunders; 2009. p. 102.Google Scholar
  2. 2.
    Ueland K, Metcalfe J. Circulatory changes in pregnancy. Clin Obstet Gynecol. 1975;18:41–50.PubMedCrossRefGoogle Scholar
  3. 3.
    Laird-Meeter K, Van de Ley G, Bom TH, et al. Cardiocirculatory adjustments during pregnancy—an echocardiographic study. Clin Cardiol. 1979;2:328–32.PubMedCrossRefGoogle Scholar
  4. 4.
    James C, Banner T, Caton D. Cardiac output in women undergoing cesarean section with epidural or general anesthesia. Am J Obstet Gynecol. 1989;160:1178.PubMedCrossRefGoogle Scholar
  5. 5.
    Crapo R. Normal cardiopulmonary physiology during pregnancy. Clin Obstet Gynecol. 1996;39:3–16.PubMedCrossRefGoogle Scholar
  6. 6.
    Prowse CM, Gaensler EA. Respiratory and acid–base changes during pregnancy. Anesthesiology. 1965;26:381–92.PubMedCrossRefGoogle Scholar
  7. 7.
    Elkus R, Popovich J. Respiratory physiology in pregnancy. Clin Chest Med. 1992;13:555–65.PubMedGoogle Scholar
  8. 8.
    McAuliffe F, Kametas N, Costello J, et al. Respiratory function in singleton and twin pregnancy. BJOG. 2002;109:765–9.PubMedCrossRefGoogle Scholar
  9. 9.
    Lucius H, Gahlenbeck H, Kleine H-O, et al. Respiratory functions, buffer system, and electrolyte concentrations of blood during human pregnancy. Respir Physiol. 1970;9:311–7.PubMedCrossRefGoogle Scholar
  10. 10.
    Dunlop W. Serial changes in renal hemodynamics during normal human pregnancy. BJOG. 1981;88:1.CrossRefGoogle Scholar
  11. 11.
    Conrad KP, Lindheimer MD. Renal and cardiovascular alterations. In: Lindheimer MD, Roberts JM, Cunningham FG, editors. Chesley’s hypertensive disorders in pregnancy. 2nd ed. Stamford: Appleton and Lange; 1999. p. 263–326.Google Scholar
  12. 12.
    Davison J, Hytten F. The effect of pregnancy on the renal handling of glucose. Br J Obstet Gynaecol. 1975;82:374.PubMedCrossRefGoogle Scholar
  13. 13.
    Fried A, Woodring JH, Thompson TJ. Hydronephrosis of pregnancy. J Ultrasound Med. 1983;2:255.PubMedGoogle Scholar
  14. 14.
    Girling JC, Dow E, Smith JH. Liver function tests in pre-eclampsia: importance of comparison with a reference range derived for normal pregnancy. BJOG. 1997;104:246–50.CrossRefGoogle Scholar
  15. 15.
    Ensom M, Liu P, Stephenson M. Effect of pregnancy on bone mineral density in healthy women. Obstet Gynecol Surv. 2002;57:99.PubMedCrossRefGoogle Scholar
  16. 16.
    Karlsson MK, Ahlborg HG, Karlsson C. Maternity and bone mineral density. Acta Orthop. 2005;76(1):2–13.PubMedCrossRefGoogle Scholar
  17. 17.
    Keriakos R, Bhatta SR, Morris F, Mason S, Buckley S. Pelvic girdle pain during pregnancy and puerperium. J Obstet Gynaecol. 2011;31(7):572–80.PubMedCrossRefGoogle Scholar
  18. 18.
    American College of Obstetricians and Gynecologists. ACOG practice bulletin 77: screening for fetal chromosomal abnormalities. Obstet Gynecol. 2007;109:217–27.CrossRefGoogle Scholar
  19. 19.
    Bianchi DW, Platt LD, Goldberg JD, Abuhamad AZ, Sehnert AJ, Rava RP, et al. Genome-wide fetal aneuploidy detection by maternal plasma DNA sequencing. Obstet Gynecol. 2012;119:890–901.PubMedCrossRefGoogle Scholar
  20. 20.
    Alfirevic Z, Stampalija T, Gyte GML. Fetal and umbilical Doppler ultrasound in high-risk pregnancies. Cochrane Database Syst Rev. 2010;(1), Art. No: CD007529. doi: 10.1002/14651858.CD007529.pub2
  21. 21.
    Norwitz ER, Schust DJ, Fisher SJ. Implantation and the survival of early pregnancy. N Engl J Med. 2001;345:1400–8.PubMedCrossRefGoogle Scholar
  22. 22.
    Simpson JL, Mills JL, Holmes LB, et al. Low fetal loss rates after ultrasound-proved viability in early pregnancy. JAMA. 1987;258:2555–7.PubMedCrossRefGoogle Scholar
  23. 23.
    MacDorman MFL, Kirmeyer SE, Wilson EC. Fetal and perinatal mortality, United States, 2006. Natl Vital Stat Rep. 2012;60(8).Google Scholar
  24. 24.
    The Stillbirth Collaborative Research Network Writing Group. Causes of death among stillbirths. JAMA. 2011;306:2459–68.CrossRefGoogle Scholar
  25. 25.
    Alexander JM, Bloom SL, McIntire DD, Leveno KJ. Severe preeclampsia and the very low birth weight infant: is induction of labor harmful? Obstet Gynecol. 1999;93(4):485.PubMedCrossRefGoogle Scholar
  26. 26.
    Nassar AH, Adra AM, Chakhtoura N, Gómez-Marín O, Beydoun S. Severe preeclampsia remote from term: labor induction or elective cesarean delivery? Am J Obstet Gynecol. 1998;179(5):1210.PubMedCrossRefGoogle Scholar
  27. 27.
    Haram K, Svendsen E, Abildgaard U. The HELLP syndrome: clinical issues and management. A review. BMC Pregnancy Childbirth. 2009;9:8.PubMedCrossRefPubMedCentralGoogle Scholar
  28. 28.
    Williamson C, Mackillop L. Diseases of the liver, biliary system, and pancreas. In: Creasy RK, Resnik R, Iams JD, Lockwood CJ, Moore TR, editors. Maternal-fetal medicine: principles and practice. 6th ed. Philadelphia: Saunders; 2009. p. 1059–77.Google Scholar
  29. 29.
    Woudstra DM, Chandra S, Hofmeyr GJ, Dowswell T. Corticosteroids for HELLP (hemolysis, elevated liver enzymes, low platelets) syndrome in pregnancy. Cochrane Database Syst Rev 2010;(9):CD008148.Google Scholar
  30. 30.
    Duley L, Gulmezoglu AM, Henderson-Smart DJ. Magnesium sulphate and other anticonvulsants for women with pre-eclampsia. Cochrane Database Syst Rev. 2010;11:CD000025.PubMedGoogle Scholar
  31. 31.
    Jewell D, Young G. Interventions for nausea and vomiting in early pregnancy (Cochrane review). In: The Cochrane library, issue 4. Chichester: Wiley; 2003.Google Scholar
  32. 32.
    Saleh M, Abdo K. Intrahepatic cholestasis of pregnancy: review of the literature and evaluation of current evidence. J Womens Health. 2007;16(6):833–41.CrossRefGoogle Scholar
  33. 33.
    Williamson C, Gorelik J, Eaton BM, et al. The bile acid taurocholate impairs rat cardiomyocyte function: a proposed mechanism for intra-uterine fetal death in obstetric cholestasis. Clin Sci (Lond). 2001;100(4):363–9.CrossRefGoogle Scholar
  34. 34.
    Gorelik J, Harding SE, Shevchuk AI, et al. Taurocholate induces changes in rat cardiomyocyte contraction and calcium dynamics. Clin Sci (Lond). 2002;103(2):191–200.CrossRefGoogle Scholar
  35. 35.
    Williamson C, Miragoli M, Sheikh Abdul Kadir S, Abu-Hayyeh S, Papacleovoulou G, Geenes V, Gorelik J. Bile acid signaling in fetal tissues: implications for intrahepatic cholestasis of pregnancy. Dig Dis. 2011;29(1):58–61.PubMedCrossRefGoogle Scholar
  36. 36.
    Kenyon AP, Percy CN, Girling J, et al. Obstetric cholestasis, outcome with active management: a series of 70 cases. BJOG. 2002;109(3):282–8.PubMedCrossRefGoogle Scholar
  37. 37.
    Gorelik J, Shevchuk A, de Swiet M, et al. Comparison of the arrhythmogenic effects of tauro- and glycoconjugates of cholic acid in an in vitro study of rat cardiomyocytes. BJOG. 2004;111(8):867–70.PubMedCrossRefGoogle Scholar
  38. 38.
    Williamson C, Hems L, Goulis D, et al. Clinical outcome in a series of cases of obstetric cholestasis identified via a patient support group. BJOG. 2004;111(7):676–81.PubMedCrossRefGoogle Scholar
  39. 39.
    Sibai BM. Imitators of severe pre-eclampsia. Semin Perinatol. 2009;33:196–205.PubMedCrossRefGoogle Scholar
  40. 40.
    Vigil-DeGracia P, Lavergue JA. Acute fatty liver of pregnancy. Int J Gynecol Obstet. 2001;72:193–5.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2014

Authors and Affiliations

  1. 1.Department of Obstetrics and GynecologyUniversity of Utah Health Sciences Center and Intermountain Health CareSalt Lake CityUSA
  2. 2.Department of Obstetrics and GynecologyUniversity of Utah Health Sciences CenterSalt Lake CityUSA

Personalised recommendations